AOK - DIE GESUNDHEITSKASSE FÜR NIEDERSACHSEN has floated a tender for Contract notice: Medicinal products for obstructive airway diseases. The project location is Germany and the tender is closing on 27 Mar 2022. The tender notice number is 156782-2020, while the TOT Ref Number is 42020711. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Germany

Summary : Contract notice: Medicinal products for obstructive airway diseases

Deadline : 27 Mar 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 42020711

Document Ref. No. : 156782-2020

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AOK - DIE GESUNDHEITSKASSE FÜR NIEDERSACHSEN
Office Name: AOK - Die Gesundheitskasse für Niedersachsen
Address: Hildesheimer Str. 273
Town: Hanover
Postal Code: 30519
Contact Point: Unternehmensbereich Arzneimittelmanagement



Germany
Email :rabattvertraege@nds.aok.de
URL :www.aok.de

Tender Details

Object of the contract
Medicinal products for obstructive airway diseases

Description: Contract notice: Medicinal products for obstructive airway diseases

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: The most economic tender
CPV code: 33673000, 33673000
CPV Description: Medicinal products for obstructive airway diseases.

Conclusion of a non-exclusive discount contract in accordance with Section 130a (8) SGB V for medicinal products with the active ingredient combination of vilanterol and fluticasone furoate (ATC code: R03AK10)

Conclusion of a non-exclusive discount contract in accordance with Section 130a (8) SGB V on drugs with the active ingredient combination of vilanterol and fluticasone furoate (ATC code: R03AK10) within the period from 1.6.2020 to 31.5.2022 with the possibility of concluding the contract at any time during the term ("open house model").

The AOK The health insurance fund for Lower Saxony intends to open contracts until the entry into force after an open invitation to tender the regulations of the 4th part of the GWB, non-exclusive drug discount contracts to theActive ingredient combination of vilanterol and fluticasone furoate (ATC code: R03AK10) with all possible market participants (pharmaceutical companies or communities of pharmaceutical companies) in the so-called "open house model".

The AOK Lower Saxony will not make a selection decision and will involve any interested pharmaceutical company submit identical contract offer IIn the open house model, uniform conditions apply to all participants. Contract contents, conditions and access procedures are standardized, individual negotiations are fundamentally not conducted. The contract runs for a maximum of twenty-four months, the earliest contract start is June 1st, 2020. All contracts end no later than May 31, 2022, regardless of the date of the respectiven conclusion of contract. An entry or a contract can be made within the twenty-four month period on the first of each month. There is a right of termination 6 weeks at the end of each month. AOK Lower Saxony reserves the right to replace the non-exclusive open house discount contracts with exclusive discount contracts during the term of the contract. With the IOnce exclusive discount contracts come into force, the open-house contracts will be terminated in accordance with the contractual regulation. H. the open house contracts end automatically. According to the experience of the AOK Lower Saxony, exclusive discount contracts generally occur 6 to 8 months after the corresponding announcement of the advertisement has been published in the supplement to the Official Journal of theEuropean Union in force. The future contract partners in the open house model are requested to inform themselves regularly about these announcements in the supplement to the Official Journal of the European UnionThe active ingredient combination of vilanterol and fluticasone furoate will be completed for the first time with effect from June 1, 2020. Interested parties who would like to become contractual partners on this date must submit the contract documents to be submitted by April 27, 2020 to the address specified in the contract documents. It depends on the access to the AOK Lower Saxony. Later contract conclusionThese are possible on the first of a month during the twenty-four month maximum term. Organizationally, a lead time of generally 35 calendar days on the part of the AOK is necessary in order to carry out the necessary work, e.g. B. to be able to guarantee the contract notification in the Lauer-Taxe (r). The exact entry deadlines will be announced with the contract documents. In the presentPublication is not an award of a public contract within the meaning of Directive (2014/24 / EU) or the GWB. In order to ensure the greatest possible degree of transparency for the intended contracts, the publication is published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, Aucontract notice used. The resulting conceptual requirements, such as the description of the procedure "open procedure", are due solely to the use of this notice form and the publication platform. A further significance, in particular submission to subcontracting regulations, insofar as they are not legally binding, is damit not connected.


Internet address (URL): www.aok.de

Documents

 Tender Notice